UCSB researchers working at the interface of engineering and the molecular sciences are creating a new paradigm for point-of-care diagnostics. In particular, CBE researchers are using advanced microfluidics and molecular signal transduction to develop broad new classes of rapid, precise, cost-effective diagnostic tools.
Researchers at the CBE use advanced computational tools and high throughput experimental biology enabled by novel discovery tools to understand complex biological systems. They aim for insights into ailments such as cancer, diabetes, Alzheimer’s, stroke, haemorrhage and post-traumatic stress disorder.
Biomaterials are a crucial component of modern medicine. They are at the heart of revolutionary medical technologies such as prostheses, regenerative medicine, sensors and drug delivery. UCSB researchers are developing new biomaterials that have better functionality, processability and biocompatibility.
Drug delivery is the science and engineering involved in converting potent biomolecules into practical medical therapies. Pills and injections are the most commonly used means of drug delivery, but CBE researchers are exploring revolutionary new ways to treat diseases such as diabetes, cancer and cardiovascular diseases with much greater precision and efficiency. Methods they’re exploring include using nanoparticles, and self-assembling nanomoleculars to deliver drugs to particular sites in the body, and needle-less systems to deliver drugs through skin patches and oral pills.
Bioengineering-related Campus-wide Research Events CalendarDetails
CBE/ENGR 225 Seminar Presents: Andrew deMello, Ph.D., Professor of Biochemical Engineering Department of Chemistry and Applied Biosciences Institute of Chemical and Bioengineering, ETH Zürich, Host: Sumita Pennathur
Tuesday, February 28, 2017 @ 4pm in Room #ESB 2001